600763 通策医疗
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)8.00214.06717.71127.94024.960
总资产报酬率 ROA (%)5.0978.96910.84717.52817.124
投入资产回报率 ROIC (%)5.82310.23412.53720.94019.593

边际利润分析
销售毛利率 (%)40.83038.53040.81446.05745.166
营业利润率 (%)28.91025.01026.99635.05932.504
息税前利润/营业总收入 (%)30.45626.64528.85835.87633.302
净利润/营业总收入 (%)26.05920.32022.64728.27126.101

收益指标分析
经营活动净收益/利润总额(%)92.74591.20993.42593.13193.458
价值变动净收益/利润总额(%)6.0678.4925.1905.7605.715
营业外收支净额/利润总额(%)-0.202-0.4320.553-0.0310.210

偿债能力分析
流动比率 (X)1.4151.5032.3291.6341.817
速动比率 (X)1.3761.4652.2811.6011.778
资产负债率 (%)30.70431.35829.80436.53623.366
带息债务/全部投入资本 (%)6.8627.8313.8226.547--
股东权益/带息债务 (%)1,067.846922.4611,919.2771,039.440723.901
股东权益/负债合计 (%)208.476202.042215.512159.127300.290
利息保障倍数 (X)18.97415.29516.85343.33645.662

营运能力分析
应收账款周转天数 (天)18.44415.33211.8169.0610.000
存货周转天数 (天)5.3954.9074.8374.5600.000